Molecular Imaging: A Promising Tool to Monitor Islet Transplantation

Molecular Imaging Laboratory, MGH/MIT/HMS Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, 02129, USA.
Journal of Transplantation 10/2011; 2011:202915. DOI: 10.1155/2011/202915
Source: PubMed

ABSTRACT Replacement of insulin production by pancreatic islet transplantation has great potential as a therapy for type 1 diabetes mellitus. At present, the lack of an effective approach to islet grafts assessment limits the success of this treatment. The development of molecular imaging techniques has the potential to fulfill the goal of real-time noninvasive monitoring of the functional status and viability of the islet grafts. We review the application of a variety of imaging modalities for detecting endogenous and transplanted beta-cell mass. The review also explores the various molecular imaging strategies for assessing islet delivery, the metabolic effects on the islet grafts as well as detection of immunorejection. Here, we highlight the use of combined imaging and therapeutic interventions in islet transplantation and the in vivo monitoring of stem cells differentiation into insulin-producing cells.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: At the present time, the non-invasive imaging of pancreatic insulin-producing cells in human subjects remains a challenge. In such a perspective, the present study deals with the secretory and metabolic effects of three distinct non-targetted and ten distinct targetted nanoparticles, as investigated in vitro in rat isolated pancreatic islets incubated for 90 min in the absence or presence of these nanocontainers. Except when the islets were exposed to high concentrations of nanoparticles (NC) filled with either iron oxide (FeOx) particles (50 nM or more) or quantum dots (QD) (300 nM or more), no significant changes in insulin output were observed in response to either D-glucose (8.3 and/or 16.7 mM), 2-ketoisocaprotate (10.0 mM), or the combination of L-leucine (10.0 mM) and L-glutamine (10.0 mM). Likewise, only minor changes or, as a rule, no significant effect were observed for the utilization of D-[5-3 H]glucose, oxidation of D-[U-14 C]glucose and paired 14 CO2/ 3 HOH ratio in islets incubated in the presence of 8.3 or 16.7 mM D-glucose. These findings are thus compatible with further investigations on the possible use of selected nanoparticles for the non-invasive imaging of pancreatic insulin-producing cells.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The objective of this study was to explore the feasibility of baculovirus vector-mediated sodium iodide symporter (NIS) gene delivery to monitor islet transplantation. Baculovirus vectors expressing green fluorescent protein (GFP) or NIS (Bac-GFP and Bac-NIS) were established using the Bac-to-Bac baculovirus expression system. The GFP expression of Bac-GFP-infected rat islets was observed in vitro by fluorescence microscopy. Iodine uptake and inhibition of iodine uptake by NaClO4 in Bac-NIS-infected islets were dynamically monitored in vitro. Bac-GFP- or Bac-NIS-infected islets were implanted into the left axillary cavity of NOD-SCID mice, and fluorescence imaging and (125)I NanoSPECT/CT imaging were subsequently performed in vivo. Bac-GFP efficiently infected rat islets (over 95% infected at MOI=40), and the expression of GFP lasted approximately two weeks. NaClO4 could inhibit iodine uptake by Bac-NIS-infected islets. In vivo imaging revealed that the fluorescence intensity of the transplant sites in Bac-GFP-infected groups was significantly higher than in the non-infected group. Grafts could be clearly observed by (125)I NanoSPECT/CT imaging for up to 8 h. Baculovirus vectors are powerful vehicles for studying rat islets in gene delivery. It is feasible to use a baculovirus vector to delivery an NIS gene for non-invasive monitoring transplanted islets in vivo by the expression of the target gene.
    Nuclear Medicine and Biology 10/2013; DOI:10.1016/j.nucmedbio.2013.10.009 · 2.41 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Diabetes mellitus contributes to significant morbidity and mortality worldwide. Translational medicine and research facilitate the transition of in vitro and experimental animal research to human applications. Molecular imaging is one of the powerful tools for translational research in diabetes, which accelerates transition of laboratory hypotheses into the clinic. These imaging tools are also instrumental for furthering our understanding about the causes that trigger diabetes and facilitate its progression. Imaging of therapeutic response is yet another avenue that can be explored in our attempt to find a cure for this disease. In this review we briefly summarize molecular imaging studies that show promise for clinical translation. Emphasis is placed on imaging of endogenous and transplanted beta cell mass, including application of various imaging modalities and approaches. Finally, the review attempts to define the future role of these non-invasive imaging techniques in diabetes research and clinical care.
    09/2013; 1(3). DOI:10.1007/s40134-013-0019-7

Preview (2 Sources)

Available from